- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Stressor, Psychological in Japan
Total 24 results
-
Nagoya City UniversityAichi Health Promotion FoundationCompleted
-
Japan Science and Technology AgencyUniversity of Toyama; Chiba UniversityCompletedTrauma | Posttraumatic Stress DisorderJapan
-
Japan Science and Technology AgencyUniversity of Toyama; Chiba UniversityCompletedTrauma | Posttraumatic Stress DisorderJapan
-
GlaxoSmithKlineTerminatedStress Disorders, Post-Traumatic | Post-Traumatic Stress DisorderJapan
-
Chiba UniversityCompletedPosttraumatic Stress DisordersJapan
-
BayerRegeneron PharmaceuticalsCompletedWet Macular DegenerationJapan
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedPosttraumatic Stress DisorderJapan
-
BayerCompleted
-
Eli Lilly and CompanyICOS CorporationCompleted
-
Taiho Pharmaceutical Co., Ltd.CompletedStress Urinary IncontinenceJapan
-
Taiho Pharmaceutical Co., Ltd.CompletedStress Urinary IncontinenceJapan
-
Translational Research Center for Medical Innovation...Shinshu University HospitalCompleted
-
BayerCompletedSexual Dysfunction | Erectile Dysfunction | Spinal Cord InjuryJapan
-
Taiho Pharmaceutical Co., Ltd.CompletedStress Urinary IncontinenceJapan
-
Aichi Gakuin UniversityCompletedInflammation | Metabolic Syndrome | Oxidative StressJapan
-
Center for Supporting Hematology-Oncology TrialsBayerCompleted
-
Osaka UniversityUnknown
-
Nagoya UniversityCompletedUrinary Incontinence , StressJapan
-
Japanese Society of Intensive Care MedicineCompletedHyperthermia | FeverJapan, Korea, Republic of
-
Philip Morris Products S.A.CompletedSmoking | Inflammation | Oxidative Stress | Smoking AbstinenceJapan, Germany, Czechia, Greece
-
Eli Lilly and CompanyActive, not recruitingAicardi Goutieres Syndrome | Nakajo-Nishimura Syndrome | Chronic Atypical Neutrophilic Dermatosis With Lipodystrophy and Elevated Temperature Syndrome | STING-Associated Vasculopathy With Onset in InfancyJapan
-
Novartis PharmaceuticalsCompletedPeriodic Fevers SyndromeJapan
-
Novartis PharmaceuticalsCompletedMalignant MelanomaCanada, Italy, Czechia, Australia, France, Greece, Israel, Russian Federation, Sweden, United Kingdom, Hungary, Slovakia, Slovenia, Japan, Turkey, Argentina, Finland, Norway, Brazil, Latvia, Lithuania, Poland, Portugal